Acotec Scientific and Boston Scientific Enter Acquisition and Collaboration Agreement
China-based Acotec Scientific Holdings Ltd (HKG: 6669) and US major Boston Scientific Corporation (NYSE: BSX)...
Biogen’s Aducanumab Administered to Chinese Patient for First Time
US major Biogen’s (NASDAQ: BIIB) Alzheimer’s disease (AD) therapy aducanumab has been administered to a...
Stemirna Therapeutics’ COVID-19 mRNA Vaccine Gets EUA in Laos
Stemirna Therapeutics Co., Ltd, an mRNA drug developer based in Shanghai, has obtained Emergency Use...
Medbanks Set for IPO on Hong Kong Stock Exchange
Sipai Health Technology Co., Ltd, also known as Medbanks, is set to make an initial...
Fujian Cosunter Completes Enrollment for Phase I Study of GST-HG171
China-based Fujian Cosunter Pharmaceutical Co., Ltd (SHE: 300436) announced the completion of the enrollment of...
Alphamab Oncology Updates Clinical Studies for KN046 and KN026 at SABCS 2022
China-based Alphamab Oncology (HKG: 9966) updated the clinical studies for its KN046 and KN026 at...
Roche and Zhongshan Hospital Collaborate on Clinical Studies and Innovation Center
Swiss giant Roche’s (SWX: ROG) China unit and Roche Diagnostics’ China unit entered into a...
ASH 2022: China Biotechs Showcase Latest Clinical Trial Results
The American Society of Hematology (ASH) 2022 annual meeting, held online and offline in New...
Merck Partners with Tsinghua Shenzhen for Organoid 3D Printing System
Germany giant Merck (NYSE: MRK) struck a three-year partnership with Tsinghua Shenzhen International Graduate School,...
Luye Pharma Group Hands Over Seroquel Distribution Rights to DCH Auriga in Singapore
China-based Luye Pharma Group announced that it is handing Singapore distribution and marketing rights to...
RemeGen’s RC118 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers
China-based RemeGen Ltd announced that its antibody drug conjugate (ADC) drug candidate RC118 has obtained...
Innovent Biologics Presents Clinical Study Results at ESMO-IO 2022
China-based Innovent Biologics Inc. (HKG: 1801) announced the presentation of two clinical studies at the...
NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents
The National Medical Products Administration released a notification extending the validation period of approvals for...
Science Standard Medical Testing Raises Pre-Series A Funding
Science Standard Medical Testing, a professional third-party testing institution based in Changzhou, reportedly raised “tens...
Phanes Therapeutics and BeiGene Partner on Phase I Study of PT199
Sino-US biotech Phanes Therapeutics Inc. announced a clinical study cooperation and supply agreement with China-based...
XtalPi Partners with CTTQ for AI-Driven Small-Molecule Drug Development
Sino-US artificial intelligence (AI) firm XtalPi Inc. struck a partnership with China-based Jiangsu Chia Tai...
Harbour BioMed Concludes Phase I Study for HBM4003 in Advanced Melanoma
Harbour BioMed (HBM; HKG: 2142), a biotech operating out of the United States, the Netherlands,...
Frontier Biotechnologies Partners with Yuyue Med for FB2001 Atomizer
China-based Frontier Biotechnologies Inc. (SHA: 688221) announced a strategic collaboration agreement with compatriot firm Jiangsu...
Harbour BioMed’s Nona Biosciences Licenses Antibody Platform to Kelun-Biotech
Harbour BioMed (HKG: 2142), a biotech operating out of the Netherlands, the United States, and...
ExoNeuglia Secures Angel Funding for iPSC-Based Cell Therapy
ExoNeuglia, a stem-cell-focused biotech based in Suzhou, reportedly raised “tens of millions” of renminbi in...